Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05446558
Other study ID # IIBSP-ANA-2021-16
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 28, 2022
Est. completion date January 2023

Study information

Verified date October 2022
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Anna Sánchez López
Phone +34686274695
Email asanchezlope@santpau.cat
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Advantages of laparoscopic right colectomy with intracorporeal anastomosis (IA) compared to extracorporeal anastomosis (EA) are widely studied. Nowadays we can conclude, with a high level of scientific evidence, that there are a number of short-term clinical advantages of laparoscopic right colectomy with intracorporeal anastomosis (IA). However, there is currently no randomized studies describing long-term clinical and oncological outcomes.


Description:

Background: Little evidence has been published demonstrating the advantages of IA versus EA. Recent publications show the superiority of IA in terms of early functional digestive recovery, a shorter surgical incision, a lower need for analgesia, lower blood loss, and lower postoperative Clavien-Dindo grade. These results are similar to other further published studies, including multicenter randomized clinical trials and meta-analyses. Methods: This is a a long-term clinical follow-up study of 140 patients included preaviously in the single-blind single-center randomized prospective clinical trial conducted at the Hospital de la Santa Creu i Sant Pau (HSCSP) between 2015-2018; in which 30-day clinical outcomes after laparoscopic right colectomy for colon cancer with IA vs EA anastomosis were compared. In this new trial, prospective clinical follow-up of the included 140 patients, randomized in two groups IA and EA, will be carried out, with a minimum time of 3 years. The main objective of the study will be: -Comparing long-term oncological outcomes of IA vs. EA anastomosis in laparoscopic right colectomy for malignant neoplasm. The secondary objectives will be: - Analyzing the appearance of abdominal wall hernias and episodes of occlusion. - Describing the direct costs of both techniques retrospectively, through the financial records of the HSCSP institution. The main hypothesis will be: -IA is not inferior compared to EA in terms of oncological and clinical results, with a lower rate of abdominal postoperative hernias and occlusive/subocclusive episodes. A regular prospective clinical follow-up through periodic medical visits and complementary tests established by the criteria of the Colorectal Cancer management protocol (document agreed by the HSCSP Colorectal Tumors Committee) will be conducted. For the economic evaluation, all direct in-hospital costs that were registered by the HSCSP management will be analysed. Extensive written information and an informed consent about the study will be provided to the patient. The study does not entail any risk for the patient as it does not interfere with the usual follow-up or require extraordinary complementary studies.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date January 2023
Est. primary completion date December 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Neoplasms settled in the cecum, right colon, hepatic flexure or proximal transverse colon - Surgical procedure with curative purpose. - American Society of Anaesthesiologists Physical Status (ASA) I, II and III. - Elective surgery. - Signed Informed Consent. Exclusion Criteria: - Denial of informed consent. - Advanced neoplasia (Stage IV) - Urgent surgery. - ASA IV. - Bening colonic disease, such Ulcerative Colitis or Crohn Disease - Multivisceral procedures performed

Study Design


Intervention

Procedure:
Intracorporeal anastomosis
Iso or anti-peristaltic side-to-side ileo-colonic anastomosis with Echelon Endopatch and closure of the defect with running suture or another firing of Echelon Endopatch. The surgical specimen will be retrieved through a Pfannenstiel incision. Device: Use of an Echelon Endopatch Powered Device to perform an ileocolonic side-to-side anastomosis.
Extracorporeal anastomosis
A transverse incision in the right upper quadrant will be performed. An iso or anti-peristaltic side-to-side ileo-colonic anastomosis with Proximate Linear Cutter device and Proximate Stapler. Device: Use of a Proximate Linear Cutter device to perform a side-to-side ileo-colonic anastomosis.Use of a Proximate stapler to the closure of the defect associated with the creation of the side-to-side ileo-colonic anastomosis.

Locations

Country Name City State
Spain Hospital de la Santa Creu i Sant Pau Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

References & Publications (2)

Bollo J, Salas P, Martinez MC, Hernandez P, Rabal A, Carrillo E, Targarona E. Intracorporeal versus extracorporeal anastomosis in right hemicolectomy assisted by laparoscopy: study protocol for a randomized controlled trial. Int J Colorectal Dis. 2018 Nov;33(11):1635-1641. doi: 10.1007/s00384-018-3157-9. Epub 2018 Sep 6. — View Citation

Bollo J, Turrado V, Rabal A, Carrillo E, Gich I, Martinez MC, Hernandez P, Targarona E. Randomized clinical trial of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy (IEA trial). Br J Surg. 2020 Mar;107(4):364-372. doi: 10.1002/bjs.11389. Epub 2019 Dec 17. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Overall survival Percentage of patients alive after a 3-years follow-up-period since the laparoscopic right colectomy is performed 3 years
Secondary Disease-free survival Percentage of patients alive without any type of recurrence (local or distant) after a 3-years follow-up-period since the laparoscopic right colectomy is performed 3 years
Secondary Local recurrence Percentage of patients that experiment disease recurrence which is placed in the previously operated area 3 years
Secondary Distant recurrence Percentage of patients that experiment disease recurrence which is placed in a different area from the previously operated region (intraperitoneal, liver, lung metastases, etc) 3 years
Secondary Incisional hernia Percentage of patients that present an abdominal hernia settled on any of the incisions performed during the laparoscopic right colectomy 3 years
Secondary Intestinal obstruction Percentage of patients that experiment mechanical impairment or complete arrest of the passage of contents through the intestine due to pathology that causes blockage of the bowel. 3 years
Secondary Cost of surgical material Price (in euro) of the material used in the operating room in each procedure Intraoperative time
Secondary Cost of operative room Price (in euro) of the total amount of hours of surgical time per each procedure Intraoperative time
Secondary Cost per global hospitalization Price (in euro) of the total amount of days of hospitalization per each group Time from the first day of operation until the day that the patient is discharged from the hospital
Secondary Cost per ICU hospitalization Price (in euro) of the total amount of days of hospitalization in Intensive Care Unit per each group Time from the first day of entry into ICU until the day that the patient is transfered to Surgery Department
Secondary Cost of tests during hospitalization Price (in euro) of the total amount of costs related to laboratory and diagnosis during the hospitalization period, per each group Time from the first day of operation until the day that the patient is discharged from the hospital
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT03457454 - Reducing Rural Colon Cancer Disparities
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Completed NCT04079478 - The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT05147545 - Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects N/A
Recruiting NCT05026268 - The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis N/A
Not yet recruiting NCT03277235 - Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients N/A
Active, not recruiting NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
Active, not recruiting NCT02959541 - PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer N/A
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Recruiting NCT02526836 - Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Phase 2/Phase 3